Cognitive Aging:  What Every Mental Health Worker Needs to Know

Dan G. Blazer, M.D., M.P.H., Ph.D.

Introduction

Dan G. Blazer, M.D., M.P.H., Ph.D. is a J.P. Gibbons Professor Emeritus of Psychiatry and Behavioral Sciences at Duke University Medical Center.  He is a Professor of Community and Family Medicine at Duke and also serves as Adjunct Professor in the Department of Epidemiology, School of Public Health, University of North Carolina.  Following nine years in academic administration (two as Chair of the Department of Psychiatry and seven as Dean of Medical Education at Duke University School of Medicine) Dr. Dan G. Blazer returned to teaching, research and practice in July of 1999.  From September 1, 2002 until August 30, 2003 he was a fellow at the Center for Advanced Studies of the Behavioral Sciences at Stanford University. He is the author or editor of 40 books, author or co-author of over 220 published abstracts and over 480 peer-reviewed articles.  He is also the author or co-author of over 180 book chapters.  Many of the book chapters and scientific articles are on the topics of late life depression, epidemiology, consultation liaison psychiatry, the interface between religion and psychiatry, and the epidemiology of substance use disorders.

Dr. Blazer has been the principal investigator on many projects funded by federal grants, state grants and grants funded by private foundations.  Most of these research projects have focused on the prevalence of physical and mental illness in the elderly such as the Epidemiologic Catchment Area Project and the Established Populations for Epidemiologic Studies of the Elderly.  He has served as the Principal Investigator of the Duke University EPESE, the Piedmont Health Survey of the Elderly and the MacArthur Field Studies of Successful Aging.  He also was the original PI of the Duke Clinical Research Center for the Study of Depression in Late Life and has been funded as PI for a number of training grants as well as the Data and Statistical Coordinating Center for the Clinical Trials Network of the National Institute of Drug Abuse. 

Learning Objectives

1. Define and recognize cognitive aging in psychiatric patients.

2. Cite three areas where there is significant evidence for intervening in cognitive aging.

3. Cite three areas where interventions for cognitive aging have not been proven effective.

Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu.

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
 

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D. - Mayo Clinic

Grant Support: AssureRx, Janssen R&D, Myriad, Pfizer Consultant: Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel: American Physician Institute, CME Outfitters

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

Speaker:  Dan G. Blazer, M.D., M.P.H., Ph.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

None